I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 82% ± 19% | |
| endothelial cell | 11 studies | 34% ± 10% | |
| astrocyte | 9 studies | 36% ± 17% | |
| glutamatergic neuron | 5 studies | 29% ± 7% | |
| epithelial cell | 5 studies | 26% ± 10% | |
| type II pneumocyte | 5 studies | 19% ± 4% | |
| neuron | 4 studies | 33% ± 13% | |
| microglial cell | 4 studies | 40% ± 14% | |
| GABAergic neuron | 4 studies | 27% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 1% | |
| oligodendrocyte precursor cell | 3 studies | 38% ± 20% |
